Abstract

Improved early healing after drug eluting stent (DES) implantation may reduce the risk of early stent thrombosis. We aimed to compare early healing patterns after implantation of a 74 µm thick, everolimus-eluting biodegradable polymer stent (Synergy, Boston Scientific, USA) or a 120 µm thick,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call